Related Experiment Video
Updated: Oct 11, 2026

Fibroblast-Derived 3D Matrix System Applicable to Endothelial Tube Formation Assay
Published on: December 26, 2019
Increased potassium concentration inhibits stimulation of vascular smooth muscle proliferation by PDGF-BB and bFGF
1Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson 39216-4505, USA. mag@gwgate.nhlbi.nih.gov
Abstract:
The effects of changes in extracellular potassium concentration on the rate of vascular smooth muscle cell proliferation stimulated by cytokines and serum were analyzed in vitro. To analyze the DNA synthesis response, cells from swine coronary artery were grown in DMEM medium containing 3, 4, 5, or 6 mmol/L potassium together with 20 ng/mL platelet-derived growth factor BB (PDGF-BB), 25 ng/mL basic fibroblast growth factor (bFGF), or 5% fetal bovine serum (FBS), with [methyl 3H] thymidine added, for 24 h. Proliferation responses were analyzed in cells grown in medium with potassium concentrations of 3, 4, 5, or 6 mmol/L, together with either 20 ng/mL PDGF-BB, 25 ng/mL bFGF, or 5% FBS, for 7 days, then harvested and counted. Highly significant inverse relationships were observed between potassium concentration and 3H-thymidine incorporation stimulated by each of the three agonists (P < .01 for each, ANOVA), and between potassium concentration and proliferation (all P < .01, ANOVA). Elevation of potassium concentration within the physiologic range inhibits vascular smooth muscle cell DNA synthesis and proliferation.
Insights
Elevated extracellular potassium concentration significantly inhibits vascular smooth muscle cell proliferation and DNA synthesis. This finding highlights potassium
Area of Science:
- Cardiovascular Biology
- Cellular Physiology
- Molecular Medicine
Background:
- Vascular smooth muscle cells (VSMCs) are crucial for regulating blood vessel tone and structure.
- Cytokines and serum growth factors stimulate VSMC proliferation, a key process in vascular diseases.
- Extracellular potassium concentration is a critical physiological parameter influencing cell function.
Purpose of the Study:
- To investigate the in vitro effects of varying extracellular potassium concentrations on VSMC proliferation.
- To determine the impact of physiological potassium levels on DNA synthesis stimulated by specific growth factors and serum.
Main Methods:
- Primary swine coronary artery VSMCs were cultured in DMEM with varying potassium concentrations (3-6 mmol/L).
- Cells were stimulated with platelet-derived growth factor BB (PDGF-BB), basic fibroblast growth factor (bFGF), or fetal bovine serum (FBS).
- DNA synthesis was assessed using [methyl-3H] thymidine incorporation, and proliferation was quantified over 7 days.
Main Results:
- A significant inverse relationship was observed between potassium concentration and [methyl-3H] thymidine incorporation stimulated by PDGF-BB, bFGF, and FBS (P < .01).
- VSMC proliferation also showed a highly significant inverse correlation with increasing potassium levels (P < .01).
- These effects were evident within the physiological range of extracellular potassium.
Conclusions:
- Physiological elevation of extracellular potassium concentration inhibits VSMC DNA synthesis and proliferation.
- Potassium may play a regulatory role in processes involving VSMC growth, such as atherosclerosis and hypertension.
- Further research is warranted to elucidate the precise molecular mechanisms underlying potassium's inhibitory effects on VSMC proliferation.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
TGF - β Signaling Pathway
GPCRs Regulate Adenylyl Cylase Activity
Two...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Antihypertensive Drugs: Vasodilators
Antihypertensive Drugs: Action of β1 Blockers
